Reversible diminished calcitonin secretion in the rat during chronic hypercalcemia.

A transient increase in serum calcitonin (CT) concentration is induced by an acute iv calcium (Ca) load, whereas in the chronic hypercalcemic state, serum CT levels, as well as CT content of the thyroid, are equivocal. The secretion of CT was tested in three models of hypercalcemia in rats: tumor induced by the hypercalcemic Walker carcinosarcoma 256 (HWCS 256), chronic parenteral Ca administration, and chronic 1,25(OH)2D3 administration. In rats with HWCS 256, serum CT levels increased from basal values of 0.21 +/- 0.11 ng/ml to a maximum of 0.42 +/- 0.20 ng/ml on day 4 after tumor transplantation, 1 day before serum Ca increased. The serum CT levels declined again the following day (day 5). In thyroidectomized, parathyroid autotransplated rats with HWCS 256, serum Ca increased 1 day earlier than in intact rats. Substitution of CT by exogenous CT injections delayed the hypercalcemia for one day. Ca loading was followed by a decreased serum CT level (delta CT); the CT content of the thyroid fell from 9.4 +/- 1.1 ng/mg wet wt to 1.0 +/- 0.3 ng/mg wet wt. While hypercalcemia was present. Also chronic intraperitoneal Ca administration induced a decrease in the CT response to a Ca load (delta CT) and a decrease in thyroid CT content from 9.32 +/- 0.58 ng/mg wet wt to 3.84 +/- 0.33 ng/mg wet wt. These changes were no longer present 4 days after stopping Ca administration. In chronic hypercalcemia induced by 1,25(OH)2D3 administration, basal serum CT levels did not vary significantly, whereas serum Ca increased to 11.8 +/- 0.46 mg/dl on day 4. CT after an acute Ca load was diminished, as was CT content of the thyroid during 1,25(OH)2D3 administration. These changes were reversible after stopping 1,25(OH)2D3 administration. During chronic hypercalcemia a reversible exhaustion of CT content of the thyroid and a diminished CT response to acute Ca stimulation was observed, while basal serum CT levels remained unchanged.

[1]  M. Ericsson,et al.  Basal and Pentagastrin‐stimulated Levels of Calcitonin in Thyroid and Peripheral Veins During Normocalcemia and Chronic Hypercalcemia in Humans , 1981, Annals of surgery.

[2]  G. Mundy,et al.  Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy. , 1980, Annals of internal medicine.

[3]  K. Becker,et al.  Limited calcitonin reserve in hyperparathyroidism , 1980, The American journal of the medical sciences.

[4]  V. Go,et al.  Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiologic range. , 1979, The Journal of clinical investigation.

[5]  L. Deftos,et al.  Calcitonin secretion in primary hyperparathyroidism. , 1979, The Journal of clinical endocrinology and metabolism.

[6]  H. Heath,et al.  Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism. , 1979, The Journal of clinical investigation.

[7]  V. Pacovský,et al.  Calcitonin activity of the thyroid gland in primary hyperparathyroidism. , 1978, Acta endocrinologica.

[8]  K. Abe,et al.  Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion. , 1976, Endocrinologia japonica.

[9]  B. Roos,et al.  Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat. , 1976, The Journal of laboratory and clinical medicine.

[10]  M. Zabel The response of thyroid C-cell system in rat to long-term hypercalcemia. , 1976, Endokrinologie.

[11]  J. Doppman,et al.  Hypercalcitonemia in bronchogenic cancer. Evidence for thyroid origin of the hormone. , 1975, JAMA.

[12]  R. Ziegler,et al.  The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. , 1975, Acta endocrinologica.

[13]  K. Becker,et al.  Radioimmunoassay of calcitonin in human plasma. , 1974, Clinical chemistry.

[14]  P. Franchimont,et al.  Human Calcitonin Radioimmunoassay in Normal and Pathological Conditions * , 1974, European Journal of Clinical Investigation.

[15]  V. Livolsi,et al.  Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. , 1973, The Journal of clinical endocrinology and metabolism.

[16]  J. Habener,et al.  Immunoassay for human calcitonin. II. Clinical studies. , 1971, Metabolism: clinical and experimental.

[17]  Y. Kameda Increased mitotic activity of the parafollicular cells of the dog thyroid in experimentally induced hypercalcemia. , 1970, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.

[18]  R. Gittes,et al.  Effects of hypercalcemia and hypocalcemia on the thyrocalcitonin content of rat thyroid glands. , 1968, Endocrinology.

[19]  Tashjian Ah,et al.  Decreased thyrocalcitonin in thyroid glands from patients with hyperparathyroidism. , 1967 .

[20]  D. Copp,et al.  Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium. , 1962, Endocrinology.

[21]  R. Gittes,et al.  Parathyroid transplants in rats; a comparison of their survival time with that of skin grafts. , 1959 .